Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-21 @ 6:36 PM
Study NCT ID:
NCT02357420
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2015-01-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Sponsor:
Allergan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-29
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-29
First Submit QC Date:
None
Study First Post Date:
2015-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-01
Results First Submit QC Date:
None
Results First Post Date:
2019-07-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-03-15
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-07-01
Last Update Post Date:
2019-07-24
Last Update Post Date Type:
ACTUAL